Drug
Tak 058
Tak 058: highest development phase Phase 1, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| TAK-058 NCT02389881 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Tak 058 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.